Experienced in Relapsing Multiple Sclerosis (RMS)

Dr. Pavel Klein

Neurology
Pavel Klein
6410 Rockledge Dr Ste 610, 
Bethesda, MD 
Offers Telehealth

Experienced in Relapsing Multiple Sclerosis (RMS)
Pavel Klein
6410 Rockledge Dr Ste 610, 
Bethesda, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Pavel Klein is a Neurologist in Bethesda, Maryland. Dr. Klein is rated as an Experienced provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Post-Traumatic Epilepsy.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Pavel Klein
6410 Rockledge Dr Ste 610, Bethesda, MD 20817
Call: 301-530-9744
Other Locations
Lurie Surgical Services PC
1400 Forest Glen Rd Ste 225, Silver Spring,, MD 20910
Call: 301-456-5810

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)
Enrollment Status: Terminated
Publish Date: October 08, 2025
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)
Enrollment Status: Completed
Publish Date: August 21, 2024
Intervention Type: Drug
Study Drug: Soticlestat
Study Phase: Phase 3
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
Enrollment Status: Completed
Publish Date: May 14, 2024
Intervention Type: Drug
Study Drug: YKP3089
Study Phase: Phase 3
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase 1, Open-Label Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: April 04, 2024
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Phase I, Open-Label, Pharmacokinetic, Dose Escalation Study of Carisbamate in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Enrollment Status: Completed
Publish Date: May 30, 2023
Intervention Type: Drug
Study Drug: Carisbamate
Study Phase: Phase 1
Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study
Enrollment Status: Completed
Publish Date: November 09, 2022
Intervention Type: Other
Study Phase: Phase 1
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
A Phase 2a, Safety, Tolerability, Pharmacokinetics, and Quantitative EEG Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
Enrollment Status: Completed
Publish Date: September 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
Ketogenic Diet Treatment Adjunctive to Radiation and Chemotherapy in Glioblastoma Multiforme: a Pilot Study
Enrollment Status: Completed
Publish Date: August 11, 2022
Intervention Type: Other
Study Phase: Phase 2
Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures
Enrollment Status: Completed
Publish Date: May 16, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
A Double-Blind, Placebo-Controlled, Inpatient, Dose-Ranging Efficacy Study of Staccato Alprazolam (STAP-001) in Subjects With Epilepsy With a Predictable Seizure Pattern
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
Rational Polytherapy Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Rational Polytherapy Using Perampanel Dual Therapy Anticonvulsant Combination Treatments of Adults With Refractory Focal Epilepsy : a Pilot Study.
Enrollment Status: Terminated
Publish Date: August 29, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 10 Less Clinical Trials

97 Total Publications

Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.
Mood and Anxiety Disorders and Suicidality in Patients With Newly Diagnosed Focal Epilepsy: An Analysis of a Complex Comorbidity.
Journal: Neurology
Published: September 22, 2025
View All 97 Publications
Similar Doctors
Elite in Relapsing Multiple Sclerosis (RMS)
Dr. Peter A. Calabresi
Neurology
Elite in Relapsing Multiple Sclerosis (RMS)
Dr. Peter A. Calabresi
Neurology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (34.6 miles away)
410-955-5000
Languages Spoken:
English
See accepted insurances

Peter Calabresi is a Neurologist in Baltimore, Maryland. Dr. Calabresi is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome.

Scott Newsome
Elite in Relapsing Multiple Sclerosis (RMS)
Dr. Scott Newsome
Neurology
Elite in Relapsing Multiple Sclerosis (RMS)
Dr. Scott Newsome
Neurology

Johns Hopkins Outpatient Center

601 North Caroline Street, Floor 5, Floor 5, 
Baltimore, MD 
 (33.5 miles away)
410-955-9441
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Neurologist Scott Newsome specializes in the care of patients with neuroimmunological and neuroinflammatory disorders of the central nervous system. He works within the Division of Neuroimmunology and Neurological Infections at The Johns Hopkins Hospital, and has special interest in evaluating and treating patients with multiple sclerosis, transverse myelitis, neuromyelitis optica and stiff person syndrome. After completing fellowship training, Dr. Newsome joined the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers, and he is the director of the Johns Hopkins Neurosciences Consultation and Infusion Center and the Stiff Person Syndrome Center. He is also director of the Johns Hopkins Neuroimmunology and Neurological Infectious Disease Fellowship Program and co-director of the Multiple Sclerosis Experimental Therapeutics Program. Dr. Newsome received his medical degree from the New York College of Osteopathic Medicine, with honors. During his neurology residency, he was awarded the Golden Apple Outstanding Resident Teaching Award, and later was chosen to be chief resident. He subsequently completed a fellowship in neuroimmunology at The Johns Hopkins Hospital with the support of a Sylvia Lawry Physician Fellowship Award from the National Multiple Sclerosis Society. Identifying and testing novel therapies and therapeutic strategies for multiple sclerosis and other neuroimmunological disorders is Dr. Newsome’s main research focus. Other research endeavors include validating the use of new quantitative clinical outcome measures and imaging techniques in multiple sclerosis and identifying risk factors of disease onset and severity, response to treatment and long-term outcomes in neuroimmunological disorders. An adviser for the National Multiple Sclerosis Society and a member of the Miller-Coulson Academy of Clinical Excellence, Dr. Newsome has also served as president of the Consortium of Multiple Sclerosis Centers. Dr. Newsome is rated as an Elite provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS).

Distinguished in Relapsing Multiple Sclerosis (RMS)
Dr. Shiv Saidha
Neurology
Distinguished in Relapsing Multiple Sclerosis (RMS)
Dr. Shiv Saidha
Neurology

Johns Hopkins University

601 N Caroline St, 
Baltimore, MD 
 (34.5 miles away)
410-955-5080
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shiv Saidha is a Neurologist in Baltimore, Maryland. Dr. Saidha is rated as a Distinguished provider by MediFind in the treatment of Relapsing Multiple Sclerosis (RMS). His top areas of expertise are Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and Stiff Person Syndrome. Dr. Saidha is currently accepting new patients.

VIEW MORE RELAPSING MULTIPLE SCLEROSIS (RMS) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Klein's expertise for a condition
ConditionClose
  • Elite
  • Epilepsy
    Dr. Klein is
    Elite
    . Learn about Epilepsy.
    See more Epilepsy experts
  • Generalized Tonic-Clonic Seizure
    Dr. Klein is
    Elite
    . Learn about Generalized Tonic-Clonic Seizure.
    See more Generalized Tonic-Clonic Seizure experts
  • Seizures
    Dr. Klein is
    Elite
    . Learn about Seizures.
    See more Seizures experts
  • Distinguished
  • Absence Seizure
    Dr. Klein is
    Distinguished
    . Learn about Absence Seizure.
    See more Absence Seizure experts
  • Autosomal Dominant Partial Epilepsy with Auditory Features
    Dr. Klein is
    Distinguished
    . Learn about Autosomal Dominant Partial Epilepsy with Auditory Features.
    See more Autosomal Dominant Partial Epilepsy with Auditory Features experts
  • Lennox-Gastaut Syndrome (LGS)
    Dr. Klein is
    Distinguished
    . Learn about Lennox-Gastaut Syndrome (LGS).
    See more Lennox-Gastaut Syndrome (LGS) experts
  • Memory Loss
    Dr. Klein is
    Distinguished
    . Learn about Memory Loss.
    See more Memory Loss experts
  • Post-Traumatic Epilepsy
    Dr. Klein is
    Distinguished
    . Learn about Post-Traumatic Epilepsy.
    See more Post-Traumatic Epilepsy experts
  • Advanced
  • Benign Rolandic Epilepsy
    Dr. Klein is
    Advanced
    . Learn about Benign Rolandic Epilepsy.
    See more Benign Rolandic Epilepsy experts
  • Dravet Syndrome
    Dr. Klein is
    Advanced
    . Learn about Dravet Syndrome.
    See more Dravet Syndrome experts
  • Epilepsy in Children
    Dr. Klein is
    Advanced
    . Learn about Epilepsy in Children.
    See more Epilepsy in Children experts
  • Epilepsy with Myoclonic-Atonic Seizures
    Dr. Klein is
    Advanced
    . Learn about Epilepsy with Myoclonic-Atonic Seizures.
    See more Epilepsy with Myoclonic-Atonic Seizures experts
  • Infant Epilepsy with Migrant Focal Crisis
    Dr. Klein is
    Advanced
    . Learn about Infant Epilepsy with Migrant Focal Crisis.
    See more Infant Epilepsy with Migrant Focal Crisis experts
  • Insomnia
    Dr. Klein is
    Advanced
    . Learn about Insomnia.
    See more Insomnia experts
View All 13 Advanced Conditions
  • Experienced
  • Anti-NMDA Receptor Encephalitis
    Dr. Klein is
    Experienced
    . Learn about Anti-NMDA Receptor Encephalitis.
    See more Anti-NMDA Receptor Encephalitis experts
  • Apoplexy
    Dr. Klein is
    Experienced
    . Learn about Apoplexy.
    See more Apoplexy experts
  • Arteriovenous Malformation
    Dr. Klein is
    Experienced
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Astrocytoma
    Dr. Klein is
    Experienced
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Klein is
    Experienced
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Autism Spectrum Disorder
    Dr. Klein is
    Experienced
    . Learn about Autism Spectrum Disorder.
    See more Autism Spectrum Disorder experts
View All 84 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.